Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study - PubMed (original) (raw)
Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study
R N Alyautdin et al. J Microencapsul. 1998 Jan-Feb.
Abstract
The possibility of using polysorbate 80-coated polybutylcyanoacrylate nanoparticles to deliver low molecular polar hydrophilic drugs to the CNS has been studied. Tubocurarine (a quaternary ammonium salt) does not penetrate the normal intact blood-brain barrier. However, the injection of this drug directly into the cerebral ventricles of the brain provokes the development of epileptiform seizures as assessed by electroencephalogram (EEG). An in situ perfused rat brain technique was used as an experimental technique together with a simultaneous recording of the EEG. Nanoparticles were prepared by butylcyanoacrylate polymerization in an acidic medium. Fifteen minutes after the introduction of tubocurarine-loaded polysorbate 80-coated nanoparticles into the perfusate, epileptiform spikes in the EEG appeared. Intraventricular injection of tubocurarine caused the appearance of the EEG seizures 5 min after administration. Neither tubocurarine solution nor tubocurarine-loaded nanoparticles without polysorbate 80 or a mixture of polysorbate 80 and tubocurarine were able to influence the EEG. Thus only the loading of tubocurarine onto the polysorbate 80-coated nanoparticles appears to enable the transport of this quaternary ammonium compound through the blood-brain barrier.
Similar articles
- Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles.
Gao K, Jiang X. Gao K, et al. Int J Pharm. 2006 Mar 9;310(1-2):213-9. doi: 10.1016/j.ijpharm.2005.11.040. Epub 2006 Jan 19. Int J Pharm. 2006. PMID: 16426779 - Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles.
Wilson B, Samanta MK, Santhi K, Kumar KP, Paramakrishnan N, Suresh B. Wilson B, et al. Eur J Pharm Biopharm. 2008 Sep;70(1):75-84. doi: 10.1016/j.ejpb.2008.03.009. Epub 2008 Mar 27. Eur J Pharm Biopharm. 2008. PMID: 18472255 - Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease.
Wilson B, Samanta MK, Santhi K, Kumar KP, Paramakrishnan N, Suresh B. Wilson B, et al. Brain Res. 2008 Mar 20;1200:159-68. doi: 10.1016/j.brainres.2008.01.039. Epub 2008 Jan 26. Brain Res. 2008. PMID: 18291351 - [Drug delivery to the brain with nanoparticles].
Aliautdin RN, Kreuter J, Kharkevich DA. Aliautdin RN, et al. Eksp Klin Farmakol. 2003 Mar-Apr;66(2):65-8. Eksp Klin Farmakol. 2003. PMID: 12962052 Review. Russian. - Nanoparticulate systems for brain delivery of drugs.
Kreuter J. Kreuter J. Adv Drug Deliv Rev. 2001 Mar 23;47(1):65-81. doi: 10.1016/s0169-409x(00)00122-8. Adv Drug Deliv Rev. 2001. PMID: 11251246 Review.
Cited by
- Future prospects of nanoparticles on brain targeted drug delivery.
Chakraborty C, Sarkar B, Hsu CH, Wen ZH, Lin CS, Shieh PC. Chakraborty C, et al. J Neurooncol. 2009 Jun;93(2):285-6. doi: 10.1007/s11060-008-9759-2. Epub 2008 Dec 2. J Neurooncol. 2009. PMID: 19048187 No abstract available. - Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics.
Shakeri S, Ashrafizadeh M, Zarrabi A, Roghanian R, Afshar EG, Pardakhty A, Mohammadinejad R, Kumar A, Thakur VK. Shakeri S, et al. Biomedicines. 2020 Jan 13;8(1):13. doi: 10.3390/biomedicines8010013. Biomedicines. 2020. PMID: 31941057 Free PMC article. Review. - The role of high-resolution imaging in the evaluation of nanosystems for bioactive encapsulation and targeted nanotherapy.
Khosravi-Darani K, Pardakhty A, Honarpisheh H, Rao VS, Mozafari MR. Khosravi-Darani K, et al. Micron. 2007;38(8):804-18. doi: 10.1016/j.micron.2007.06.009. Epub 2007 Jul 3. Micron. 2007. PMID: 17669661 Free PMC article. Review. - Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's disease.
Liu G, Men P, Perry G, Smith MA. Liu G, et al. J Nanoneurosci. 2009 Jun 1;1(1):42-55. doi: 10.1166/jns.2009.005. J Nanoneurosci. 2009. PMID: 19936278 Free PMC article. - A review of the current understanding of nanoparticles protein corona composition.
Breznica P, Koliqi R, Daka A. Breznica P, et al. Med Pharm Rep. 2020 Oct;93(4):342-350. doi: 10.15386/mpr-1756. Epub 2020 Oct 25. Med Pharm Rep. 2020. PMID: 33225259 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources